Geode Capital Management
CRVO icon

Geode Capital Management’s CervoMed CRVO Stock Holding History

Geode Capital Management’s Portfolio CRVO Stock Details CRVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$293K Buy
74,371
+8,493
+13% +$44.4K ﹤0.01% 3788
2025
Q4 		$521K Buy
65,878
+1,411
+2% +$11.3K ﹤0.01% 3573
2025
Q3 		$522K Buy
64,467
+10,211
+19% +$87.6K ﹤0.01% 3600
2025
Q2 		$341K Sell
54,256
-62,225
-53% -$530K ﹤0.01% 3680
2025
Q1 		$1.07M Buy
116,481
+1,646
+1% +$6.27K ﹤0.01% 3285
2024
Q4 		$269K Sell
114,835
-99
-0.1% -$963 ﹤0.01% 3803
2024
Q3 		$1.68M Buy
114,934
+14,042
+14% +$218K ﹤0.01% 3183
2024
Q2 		$1.73M Buy
100,892
+79,717
+376% +$1.74M ﹤0.01% 3158
2024
Q1 		$494K Buy
21,175
+5,466
+35% +$72.9K ﹤0.01% 3620
2023
Q4 		$109K Buy
15,709
+4,617
+42% +$39.9K ﹤0.01% 4160
2023
Q3 		$52.9K Sell
11,092
-323
-3% -$1.63K ﹤0.01% 4406
2023
Q2 		$56.8K Hold
11,415
– – ﹤0.01% 4479
2023
Q1 		$71.2K Hold
11,415
– – ﹤0.01% 4439
2022
Q4 		$87K Sell
11,415
-28
-0.2% -$233 ﹤0.01% 4443
2022
Q3 		$91K Hold
11,443
– – ﹤0.01% 4609
2022
Q2 		$112K Sell
11,443
-2
-0% -$25 ﹤0.01% 4545
2022
Q1 		$214K Hold
11,445
– – ﹤0.01% 4344
2021
Q4 		$261K Hold
11,445
– – ﹤0.01% 4360
2021
Q3 		$437K Buy
11,445
+721
+7% +$30K ﹤0.01% 4095
2021
Q2 		$587K Buy
10,724
+1,390
+15% +$76.8K ﹤0.01% 3864
2021
Q1 		$642K Buy
9,334
+5,925
+174% +$497K ﹤0.01% 3724
2020
Q4 		$203K Hold
3,409
– – ﹤0.01% 3880
2020
Q3 		$215K Sell
3,409
-1,122
-25% -$85.3K ﹤0.01% 3695
2020
Q2 		$331K Buy
4,531
+2,208
+95% +$134K ﹤0.01% 3510
2020
Q1 		$55K Sell
2,323
-1,026
-31% -$31.1K ﹤0.01% 3907
2019
Q4 		$115K Buy
3,349
+3,215
+2,399% +$196K ﹤0.01% 3954
2019
Q3 		$18K Hold
134
– – ﹤0.01% 4153
2019
Q2 		$28K Hold
134
– – ﹤0.01% 4137
2019
Q1 		$37K Buy
+134
New +$32.2K ﹤0.01% 4053

Other funds holding CRVO

Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return
CFG
Citizens Financial Group Providence, Rhode Island $7.19B AUM 23.93% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Cetera Investment Advisers
Cetera Investment Advisers Schaumburg, Illinois $94B AUM 20.14% 1-Year Est. Return

Geode Capital Management's CRVO Position: Q1 2026 in Review

Geode Capital Management increased its CervoMed (CRVO) stake by 13% in Q1 2026, buying an estimated $44.4K and bringing the position to 74,371 shares worth $293K. The position accounts for ﹤0.01% of the portfolio, ranked #3788.

Geode Capital Management first reported a position in CRVO in Q1 2019 and has held it in 29 quarters since. The position peaked at $1.73M in Q2 2024. 36 funds tracked by Wall St. Rank hold CRVO as of Q1 2026.

  • Geode Capital Management held 74,371 shares of CervoMed worth $293K as of Q1 2026.
  • Geode Capital Management bought 8,493 CervoMed shares in Q1 2026, an estimated $44.4K.
  • CervoMed made up ﹤0.01% of Geode Capital Management's portfolio in Q1 2026, its #3788 holding.
  • Geode Capital Management first reported a position in CervoMed in Q1 2019 and has held it in 29 quarters since.
  • Geode Capital Management's CervoMed position peaked at $1.73M in Q2 2024.
  • 36 funds tracked by Wall St. Rank held CervoMed as of Q1 2026.

Based on Geode Capital Management's 13F filing for Q1 2026, filed 15 May 2026.